Presented by
IVBM Event Coverage
Innovative Approaches in Academic Neurology Workflows
Experts at an Institute for Value-Based Medicine event held October 14, 2025, in Aurora, Colorado, explored advances in neurology care, cross-specialty collaboration, and strategies to improve access and therapy.
Technology Drives Innovation, Accessibility When Treating Chronic Kidney Disease
Experts met in Park City, Utah, on October 7, 2025, to discuss how new technologies can help address chronic kidney disease.
Redesigning Trials for Real-World Patient Complexity: A Q&A With Prerna Mewawalla, MD
Prerna Mewawalla, MD, discusses innovative strategies to enhance cancer care access, reduce clinician burden, and improve clinical trial diversity in real-world settings.
Managing Cardio-Renal-Metabolic Diseases Requires Multifactorial Approach
Speakers at the Institute for Value-Based Medicine event held September 18, 2025, in Nyack, New York, spoke about methods of managing cardio-renal-metabolic disease.
Precision Medicine Advances Highlight Ongoing Equity Challenges: Tina Bhatnagar, DO
Despite the impact of targeted treatment in oncology, much work remains to bring these therapeutics to all patients, says Bhavana (Tina) Bhatnagar, DO.
Setting the Stage for Collaborative Care to Address CKM Syndrome
Payer and health system leaders convened in Pittsburgh, Pennsylvania, on September 9, 2025, to discuss the interconnected health conditions of cardiovascular-kidney-metabolic (CKM) syndrome.
Emerging Breakthroughs in Neurodegenerative Disease Treatments: Kavita Nair, PhD, FAAN
Kavita Nair, PhD, FAAN, shares how new therapies and ongoing clinical trials are reshaping the future of neurological care and offering new hope to patients.
Barriers and Breakthroughs Ahead for Personalizing Adjuvant Therapy: Michael Hassett, MD
Michael Hassett, MD, explains the evolving landscape of HER2-positive breast cancer treatment and the role of CDK inhibition in personalized therapy strategies.
Postpandemic Breast Cancer Screening Rates Explained: Adam Brufsky, MD, PhD
Adam Brufsky, MD, PhD, addresses how the COVID-19 pandemic affected breast cancer screening rates across Pittsburgh.
How Academic Medical Centers Address Neurological Care: Kavita Nair, PhD, FAAN
Kavita Nair, PhD, FAAN, discusses academic medical centers' unique role in diagnosing and managing neurodegenerative diseases.
How Pharmacists Expand Rural Cancer Care Access: Jasmine Eugene, PharmD
Jasmine Eugene, PharmD, explains how pharmacists practicing at the top of their license improve rural oncology access and ease physician workload.
Telemedicine’s Role in Bridging Cancer Care Gaps: Clark Alsfeld, MD
Clark Alsfeld, MD, discusses how telemedicine, pharmacists, and evolving policies help overcome financial and geographic barriers in oncology care.
Pharmacy Is Essential to Navigating Breast Cancer Treatment: Danielle Roman, PharmD, BCOP
Danielle Roman, PharmD, BCOP, discusses the challenges of accessing genomic test results and managing prior authorization in patient care for breast cancer.
Diet, Lifestyle Come Into Focus for Managing Multiple Sclerosis: Rebecca Spain, MD
Diet and wellness impact multiple sclerosis management, enhancing quality of life and reducing fatigue through lifestyle changes and holistic approaches.
Expanding CAR T-Cell Access With Broader Criteria and Real-World Data: Clark Alsfeld, MD
Broader eligibility, real-world data, and community partnerships are expanding access to CAR T-cell therapy.
Inside the VA’s Hub-and-Spoke Model for Multiple Sclerosis Care: Rebecca Spain, MD
Explore how the Veteran Affairs (VA) MS Centers of Excellence enhance veteran care through a hub-and-spoke model, telehealth, and groundbreaking research.
Improving Cancer Care Equity in Louisiana: Melanie Sheen, MD
Ochsner MD Anderson expands cancer care access in Louisiana through community partnerships, technology, and strong patient-physician relationships.
How Alzheimer Treatment Delivery Must Evolve: Darla Chapman, DNP
Nurse practitioners play an essential role in diagnosing, treating, and supporting individuals living with Alzheimer disease.
Improving Clinical Trial Diversity by Building Trust: Melanie Sheen, MD
Melanie Sheen, MD, describes efforts to boost diverse clinical trial enrollment through trust, community partnerships, and equitable patient engagement.
Innovative Oncology Care Strategies Addressing Social Determinants of Health: Lingling Du, MD
Oncology care advances target social determinants of health through AI, patient education, and community engagement.
How MS Treatment Strategies Are Evolving: Rebecca Spain, MD
Early intervention and effective therapies are transforming multiple sclerosis management, enhancing patient outcomes, and delaying disability progression.
Early Alzheimer Diagnosis Key to Better Outcomes: Darla Chapman, DNP
Darla Chapman, DNP, ARNP, University of Washington, speaks on the evolution of Alzheimer diagnosis, emphasizing early detection and innovative biomarkers.
Using AI to Individualize Clinical Pathways Is the Future of Precision Oncology: Joshua K. Sabari, MD
Using artificial intelligence (AI) to specialize treatment for patients with different kinds of cancer can be a boon to clinicians looking to personalize their care.
Remote Monitoring May Improve Heart Failure Outcomes: Anitha Vijayan, MD
Guideline-directed medical therapy used with remote monitoring can potentially reduce hospitalization in patients with heart failure with ejection fraction.
Clinicians Should Look Beyond NGS When Delivering Precision Oncology: Joshua K. Sabari, MD
New methods of testing tissue and plasma beyond next-generation sequencing (NGS) could be used to deliver the best therapeutic options for patients with cancer.
Defining the Comprehensive Role of the Oncology Pharmacist in Multiple Myeloma: Marcus Flores, PharmD, BCPS, BCOP
Marcus Flores, PharmD, BCPS, BCOP, discusses the vital role of pharmacists in multidisciplinary cancer care, exploring collaboration, patient-centered strategies, and AI.
Digital, Blood-Based Innovations Transform Alzheimer Disease Detection: Ken Cohen, MD, FACP
Ken Cohen, MD, FACP, discusses how new cognitive assessment tools are improving Alzheimer disease diagnosis.
Cancer Care Strategies Addressing Social Determinants of Health: Susan Escudier, MD
Susan Escudier, MD, FACP, of Texas Oncology, suggests actionable insights to improve equitable access to patient cancer care
Overcoming SDOH Barriers in Cancer Care: Susan Escudier, MD
Incorporating tools that gauge social determinants of health can improve patient access to cancer care, explained Susan Escudier, MD.
Identifying Treatment, Support Pathways After Cognitive Screening: Ken Cohen, MD, FACP
Ken Cohen, MD, FACP, discusses how clinicians can support patients after a cognitive screening to identify meaningful next steps.
